Annual report for Jagsonpal Pharmaceuticals Ltd. for FY-2020
21-08-2020
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Intimation Of Transfer Of Equity Shares To Investor Education And Protection Fund (IEPF) Authority For Financial Year 2012-13
Pursuant to Regulation 30 read with Para A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose the following documents as required under Section 124 of the Companies Act, 2013 read with Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016:- 1. Copy of Circular Letter sent to shareholders. 2. Copy of Newspaper Advertisement published on August 07, 2020, in Business Standard (English) and Business Standard (Hindi). This is for your information and records07-08-2020
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Audited Financial Results For The Quarter And Year Ended 31 March, 2020 Along With Audit Report.
Audited financial results for the quarter and year ended 31 March, 2020 along with Audit Report.29-07-2020
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Unaudited Financial Results For The Quarter Ended 30 June, 2020 Along With Limited Review Report
Unaudited Financial Results for the quarter ended 30 June, 2020 along with Limited Review Report29-07-2020
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Board recommends Dividend
Jagsonpal Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 29, 2020, inter alia, has recommended Dividend @ 10% on Equity shares of Rs. 5/- each.29-07-2020
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Corporate Action-Board approves Dividend
The board of director at their meeting held today has declared a dividend of 10 % per equity shares subject to the approval of the shareholders at the ensuing Annual General Meeting for the financial year 2019-20.29-07-2020
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Audited Financial Results For The Quarter And Year Ended 31 March, 2020 Along With Audit Report.
Audited financial results for the quarter and year ended 31 March, 2020 along with Audit Report.29-07-2020
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - OUTCOME OF THE MEETING OF BOARD OF DIRECTORS OF JAGSONPAL PHARMACEUTICALS LIMITED HELD ON JULY 29TH, 2020
We wish to inform you that the Board of Directors of the Company at their meeting held today, (i.e. Wednesday, the 29th Day of July, 2020), have inter alia, approved and taken on record the followings: 1. Audited Standalone Financial Results of the Company for the Quarter and year ended 31st March, 2020 along with Audit Report. 2. Declaration pursuant to Regulation 33 (3) (d) of the Listing Regulations. 3. The Board recommended Dividend @ 10% on Equity shares of Rs. 5/- each. 4. Un-Audited Financial Results of the Company for the Quarter ended 30th June, 2020; 5. Limited Review Report for the Quarter ended 30th June, 2020; 6. Notice of 41st Annual General Meeting; 7. Draft Director's Report together with management discussion along with Report on Corporate Governance; 8. And other items. The meeting was commenced at 12 Noon at concluded at 14:25 Hours.29-07-2020
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Board Meeting Intimation for Intimation For The Board Meeting To Be Held On 29 July, 2020.
JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2020 ,inter alia, to consider and approve Audited Financial Results for the quarter ended 31.03.2020 and Unaudited Financial Results for the quarter ended 30.06.2020.24-07-2020
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Shareholding for the Period Ended June 30, 2020
Jagsonpal Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here21-07-2020